Precision Medicine Software Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2028

 

Precision medicine software is a new approach to the prevention and treatment of diseases such as cancer, rare illnesses, and infectious diseases. It is a synthesis of molecular biology systems and techniques. These techniques assist clinicians and physicians in efficiently monitoring patients. Precision medicine software is used to advance genetic research and genomics.

Precision Medicine Software Market is an important tool used by healthcare providers for screening prenatal aneuploidy, evaluating rare disorders, diagnosing infectious diseases, and identifying therapeutic targets in neoplasms.

The Precision Medicine Software Market is divided into on-premise and cloud-based delivery models. In 2018, the on-premise delivery mode segment accounted for the largest share of the precision medicine software market. The large share of this segment is primarily due to the numerous benefits associated with the use of on-premise delivery models. Precision Medicine Software Market models enable end users to use solutions from multiple vendors and buyers to decide when to implement software upgrades.

With the healthcare industry facing a crisis amidst the pandemic, it has been working on various solutions to combat the pandemic. The healthcare industry is engaged in conducting precision medicine research to enable a better understanding of COVID-19 and to measure the impact caused by the virus to discover potential therapies. Many governments have taken initiatives to accelerate the use of precision medicine for coronavirus.

Key Players

Syapse, Inc., 2bPrecise LLC, Foundation Medicine, Inc., Fabric Genomics, SOPHiA GENETICS SA, Gene42, Inc., LifeOmic Health, LLC, NantHealth, Inc., and Koninklijke Philips N.V. are among the key players in the precision medicine software market.